Expression of the pituitary transcription factor Ptx-1, but not that of the trans-activating factor prop-1, is reduced in human corticotroph adenomas and is associated with decreased alpha-subunit secretion.

Expression of the pituitary transcription factor Ptx-1, but not that of the trans-activating factor prop-1, is reduced in human corticotroph adenomas and is associated with decreased alpha-subunit secretion.

We have studied the expression of the pituitary transcription factors Ptx-1 and Prop-1 in a series of 34 pituitary adenomas fully characterized for in vitro hormone secretion and histological staining. In studies involving mammalian cell lines, the pituitary transcription factor Ptx-1 has been shown...

Bibliografski detalji
Glavni autori:	Skelly, R, Korbonits, M, Grossman, A, Besser, G, Monson, J, Geddes, J, Burrin, J
Format:	Journal article
Jezik:	English
Izdano:	2000

Slični predmeti

The relationship between steroidogenic factor 1 and DAX-1 expression and in vitro gonadotropin secretion in human pituitary adenomas.
od: Aylwin, S, i dr.
Izdano: (2001)

Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
od: Lidhar, K, i dr.
Izdano: (1999)

Silent corticotroph adenomas.
od: Karavitaki, N, i dr.
Izdano: (2007)

Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
od: Korbonits, M, i dr.
Izdano: (1998)

Neurocysticercosis, Meningioma, and Silent Corticotroph Pituitary Adenoma in a 61-Year-Old Woman
od: Maria del Pilar Ramirez, i dr.
Izdano: (2012-01-01)

High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma
od: Felix Behling, i dr.
Izdano: (2018-01-01)

Leptin in pituitary adenomas--a novel paracrine regulatory system.
od: Korbonits, M, i dr.
Izdano: (2001)

A bromocriptine-responsive corticotroph adenoma secreting alpha-MSH in a patient with Cushing's disease.
od: Hale, A, i dr.
Izdano: (1988)

The release of leptin and its effect on hormone release from human pituitary adenomas.
od: Korbonits, M, i dr.
Izdano: (2001)

Stereotactic radiosurgery XVI: a treatment for previously irradiated pituitary adenomas.
od: Swords, F, i dr.
Izdano: (2003)

Hexarelin as a test of pituitary reserve in patients with pituitary disease.
od: Korbonits, M, i dr.
Izdano: (1999)

Novel molecular aspects of pituitary adenomas.
od: Hubina, E, i dr.
Izdano: (2005)

Collision lesions of the sella: co-existence of craniopharyngioma with gonadotroph adenoma and of Rathke's cleft cyst with corticotroph adenoma.
od: Karavitaki, N, i dr.
Izdano: (2008)

Second brain tumour after treatment for pituitary adenoma.
od: Wass, J, i dr.
Izdano: (1992)

The molecular pathogenesis of corticotroph tumors.
od: Dahia, P, i dr.
Izdano: (1999)

The molecular pathogenesis of corticotroph tumours.
od: Dworakowska, D, i dr.
Izdano: (2012)

The pathology of pituitary adenomas from a clinical perspective.
od: Dworakowska, D, i dr.
Izdano: (2011)

The pathophysiology of pituitary adenomas.
od: Dworakowska, D, i dr.
Izdano: (2009)

Relevance of mutations in protein deubiquitinases genes and TP53 in corticotroph pituitary tumors
od: Monika Pękul, i dr.
Izdano: (2024-02-01)

Pituitary chondrosarcoma: an unusual cause of a sellar mass presenting as a pituitary adenoma.
od: Allan, C, i dr.
Izdano: (2001)

Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA).
od: Chahal, H, i dr.
Izdano: (2010)

Modeling corticotroph deficiency with pituitary organoids supports the functional role of NFKB2 in human pituitary differentiation
od: Thi Thom Mac, i dr.
Izdano: (2024-11-01)

Macrophage migration inhibitory factor expression is increased in pituitary adenoma cell nuclei.
od: Pyle, M, i dr.
Izdano: (2003)

Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas.
od: Larkin, S, i dr.
Izdano: (2014)

Differential gene expression in pituitary adenomas by oligonucleotide array analysis.
od: Morris, D, i dr.
Izdano: (2005)

AIP mutation in pituitary adenomas in the 18th century and today.
od: Chahal, H, i dr.
Izdano: (2011)

Clinical case seminar - Pituitary chondrosarcoma: An unusual cause of a sellar mass presenting as a pituitary adenoma
od: Allan, C, i dr.
Izdano: (2001)

Oncogene-induced senescence in pituitary adenomas and carcinomas.
od: Alexandraki, K, i dr.
Izdano: (2012)

Insulin-like growth factor-I (IGF-I) as a risk factor for colonic adenomas in patients with acromegaly.
od: Jenkins, P, i dr.
Izdano: (1998)

Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas.
od: Simpson, D, i dr.
Izdano: (2001)

Brief Report: AIP Mutation in Pituitary Adenomas in the 18th Century and Today.
od: Chahal, H, i dr.
Izdano: (2011)

Pituitary Adenoma Surgery Survey: Neurosurgical Centers and Pituitary Adenomas
od: David Netuka, i dr.
Izdano: (2022-01-01)

Role of regulatory factors in pituitary tumour formation.
od: Korbonits, M, i dr.
Izdano: (2004)

Angiogenesis in pituitary adenomas and the normal pituitary gland.
od: Turner, H, i dr.
Izdano: (2000)

Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
od: Morris, D, i dr.
Izdano: (2003)

A mutation and expression analysis of the oncogene BRAF in pituitary adenomas.
od: Ewing, I, i dr.
Izdano: (2007)

Lack of annexin 1 results in an increase in corticotroph number in male but not female mice.
od: Morris, J, i dr.
Izdano: (2006)

Interleukin-6, a growth promoting cytokine, is present in human pituitary adenomas: an immunocytochemical study.
od: Tsagarakis, S, i dr.
Izdano: (1992)

INCIDENCE OF PITUITARY-ADENOMA IN WOMEN
od: Robinson, N, i dr.
Izdano: (1979)

Incidence of pituitary adenoma in women.
od: Robinson, N, i dr.
Izdano: (1979)